Author

S. Chakraborti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Ciulli· 1 shared A. D. Cox· 1 shared A. Dhanwal· 1 shared A. Kroupova· 1 shared A. Varki· 1 shared A. Verma· 1 shared A. Wijaya· 1 shared B. Zheng· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Ciulli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders

A. Kroupova, V. A. Spiteri, H. Furihata, D. Darren, S. Ramachandran, Z. Rutter, S. Chakraborti, K. Haubrich, J. Pethe, D. Gonzales, A. Wijaya, M. Rodriguez-Rios, D. M. Lynch, W. Farnaby, M. Nakasone, , A. Ciulli

The paper introduces CRBNmidi, a Cereblon construct that enables high-resolution structural and biophysical studies of degraders without requiring DDB1 co-expression.

Nature Communications · Oct 15, 2024Peer-reviewedBiochemistry

Elucidation of the essentiality of lumazine synthase (RibH) for Mycobacterium tuberculosis survival and discovery of potent inhibitors for enhanced antimycobacterial therapy

M. Singh, A. Dhanwal, A. Verma, L. Augustin, N. Kumari, S. Chakraborti, N. Agarwal, D. Sriram, R. J. Dey

This study validates the essentiality of RibH in M. tb survival and identifies three potent RibH inhibitors that show antimycobacterial activity and synergy with first-line TB drugs.

bioRxiv · Jul 18, 2023 · PreprintMicrobiology

A novel sialylation site on Neisseria gonorrhoeae lipooligosaccharide links heptose II lactose expression with pathogenicity

S. Ram, S. Gulati, L. A. Lewis, S. Chakraborti, B. Zheng, R. B. DeOliveira, G. W. Reed, A. D. Cox, J. Li, F. St. Michael, J. Stupak, X.-H. Su, S. Saha, C. S. Landig, A. Varki, P. A. RICE

This paper identifies a novel sialylation site on Neisseria gonorrhoeae lipooligosaccharide that links HepII lactose expression with pathogenicity and vaccine potential.

bioRxiv · Apr 17, 2018Microbiology